Research output per year
Research output per year
Personal profile
Research areas
- Medical treatment
- Breast cancer
- Cancer
Fingerprint
Dive into the research topics where Annette Raskov Kodahl is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Researchers
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis
Gammelgaard, O. L., Terp, M. G., Kirkin, A. F., Johansen, S., Traynor, S., Vever, H., Guldberg, P., Kodahl, A. R., Gjerstorff, M. F. & Ditzel, H. J., 6. Jan 2024, In: Molecular Cancer. 23, 16 p., 6.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile63 Downloads (Pure) -
Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer
Knudsen, A.-D. M., Modvig, M. W., Vogsen, M. & Kodahl, A. R., 27. Mar 2024, In: Medical Oncology. 41, 5, 6 p., 99.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile4 Downloads (Pure) -
Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4/6 inhibitor in advanced breast cancer
Kindt, C. K., Alves, C. M. L., Ehmsen, S., Kragh, A., Reinert, T., Vogsen, M., Kodahl, A. R., Rønlev, J. D., Ardik, D., Sørensen, A. L., Evald, K., Clemmensen, M. L., Staaf, J. & Ditzel, H. J., 15. Dec 2024, In: International Journal of Cancer. 155, 12, p. 2211-2222Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile -
Cost-effectiveness of 2-[18F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study.
Naghavi-Behzad, M., Gerke, O., Kodahl, A. R., Vogsen, M., Asmussen, J. T., Weber, W., Hildebrandt, M. G. & Kidholm, K., 28. Sept 2023, In: Scientific Reports. 13, 10 p., 16315.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile23 Downloads (Pure) -
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial
Kringelbach, T., Højgaard, M., Rohrberg, K., Spanggaard, I., Laursen, B. E., Ladekarl, M., Haslund, C. A., Harsløf, L., Belcaid, L., Gehl, J., Søndergaard, L., Eefsen, R. L., Hansen, K. H., Kodahl, A. R., Jensen, L. H., Holt, M. I., Oellegaard, T. H., Yde, C. W., Ahlborn, L. B. & Lassen, U., 22. Feb 2023, In: BMC Cancer. 23, 182.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile78 Downloads (Pure)
Activities
- 2 Talks and presentations in private or public companies
-
Circulating microRNAs as potential biomarkers in Breast Cancer
Kodahl, A. R. (Lecturer)
3. May 2013Activity: Talks and presentations › Talks and presentations in private or public companies
-
Circulating microRNAs as potential biomarkers in Breast Cancer
Kodahl, A. R. (Lecturer)
20. Apr 2013Activity: Talks and presentations › Talks and presentations in private or public companies
Press/Media
-
Tripletbehandling viser lovende effekt mod metastatisk HR+/HER2- brystkræft
08/12/2023
1 Media contribution
Press/Media: Press / Media
-
Clock-stop på Trodelvy mod metastatisk triple-negativ brystkræft
30/09/2022
1 Media contribution
Press/Media: Press / Media
-
Her er Medicinrådets nye anbefalinger om ny medicin
30/09/2022
1 Media contribution
Press/Media: Press / Media
-
Her er Medicinrådets nye anbefalinger om ny medicin
30/09/2022
1 Media contribution
Press/Media: Press / Media
-
Svært syge brystkræftpatienter kan leve længere med ny behandling
13/09/2022
1 Media contribution
Press/Media: Press / Media